Alda, J. A. (2014) “Expert Recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)”, Actas Españolas de Psiquiatría, 42(Suppl. 1), pp. 1–16. Available at: https://actaspsiquiatria.es/index.php/actas/article/view/1368 (Accessed: 7 May 2024).